Tuani, Renalyn C.

HRN: 11-89-84  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/21/2025
AMPICILLIN 1GM (VIAL)
11/21/2025
11/23/2025
IV
2gms
Q6hrs
Thinly MSAF
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Reproductive Tract    Compliance to guidelines: Compliant To Guidelines